232 related articles for article (PubMed ID: 18076737)
21. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.
Hornick JL; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
Am J Surg Pathol; 2005 Mar; 29(3):372-80. PubMed ID: 15725807
[TBL] [Abstract][Full Text] [Related]
22. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
Ackroyd R; Kelty CJ; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Endoscopy; 2003 Jun; 35(6):496-501. PubMed ID: 12783347
[TBL] [Abstract][Full Text] [Related]
23. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
Robaszkiewicz M; Hardy E; Volant A; Nousbaum JB; Cauvin JM; Calament G; Robert FX; Saleun JP; Gouerou H
Gastroenterol Clin Biol; 1991; 15(10):703-10. PubMed ID: 1816011
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
25. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues.
Fang M; Lew E; Klein M; Sebo T; Su Y; Goyal R
Am J Gastroenterol; 2004 Oct; 99(10):1887-94. PubMed ID: 15447746
[TBL] [Abstract][Full Text] [Related]
26. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Kelty CJ; Ackroyd R; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1289-96. PubMed ID: 15606390
[TBL] [Abstract][Full Text] [Related]
28. Management of high-grade dysplasia in patients with Barrett's esophagus.
Montgomery E; Canto MI
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1434-9. PubMed ID: 17162237
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy.
Dunn JM; Banks MR; Oukrif D; Mackenzie GD; Thorpe S; Rodriguez-Justo M; Winstanley A; Bown SG; Novelli MR; Lovat LB
Endoscopy; 2011 Jul; 43(7):627-30. PubMed ID: 21717379
[TBL] [Abstract][Full Text] [Related]
30. The effect of photodynamic therapy (PDT) on oesophageal motility and acid clearance in patients with Barrett's oesophagus.
Globe J; Smythe A; Kelty CJ; Reed MW; Brown NJ; Ackroyd R
J Photochem Photobiol B; 2006 Oct; 85(1):17-22. PubMed ID: 16723253
[TBL] [Abstract][Full Text] [Related]
31. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
[TBL] [Abstract][Full Text] [Related]
32. Laser ablation therapies for Barrett's esophagus.
Abbas G; Pennathur A; Keeley SB; Landreneau RJ; Luketich JD
Semin Thorac Cardiovasc Surg; 2005; 17(4):313-9. PubMed ID: 16428037
[TBL] [Abstract][Full Text] [Related]
33. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC
Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy for the treatment of patients with Barrett's high-grade dysplasia and mucosal adenocarcinoma.
Triadafilopoulos G
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):136-7. PubMed ID: 16265153
[No Abstract] [Full Text] [Related]
35. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia.
Bronner MP; Overholt BF; Taylor SL; Haggitt RC; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Canto MI; Marcon N; Pedrosa M; Grace M; Depot M;
Gastroenterology; 2009 Jan; 136(1):56-64; quiz 351-2. PubMed ID: 18996379
[TBL] [Abstract][Full Text] [Related]
36. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
[TBL] [Abstract][Full Text] [Related]
37. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia.
Overholt BF
Am J Manag Care; 2000 Oct; 6(16 Suppl):S903-8. PubMed ID: 11184664
[TBL] [Abstract][Full Text] [Related]
38. Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy.
Barr H
Gastrointest Endosc Clin N Am; 2000 Jul; 10(3):421-37. PubMed ID: 10899256
[TBL] [Abstract][Full Text] [Related]
39. DNA content analysis of Barrett's esophagus by flow cytometry.
Sciallero S; Giaretti W; Bonelli L; Geido E; Rapallo A; Conio M; Ravelli P; Lombardo L; Briglia R; Lapertosa G
Endoscopy; 1993 Nov; 25(9):648-51. PubMed ID: 8119224
[TBL] [Abstract][Full Text] [Related]
40. Is there an advantage to be gained from adding digital image cytometry of brush cytology to a standard biopsy protocol in patients with Barrett's esophagus?
Borovicka J; Schönegg R; Hell M; Kradolfer D; Bauerfeind P; Dorta G; Netzer P; Binek J; Meyenberger C; Fischer JE; Spieler P
Endoscopy; 2009 May; 41(5):409-14. PubMed ID: 19418394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
